These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 22388624)
1. Radiopharmaceutical development of radiolabelled peptides. Fani M; Maecke HR Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624 [TBL] [Abstract][Full Text] [Related]
2. Radiopeptide imaging and therapy in Europe. Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555 [TBL] [Abstract][Full Text] [Related]
3. Current status and perspectives in peptide receptor radiation therapy. Ansquer C; Kraeber-Bodéré F; Chatal JF Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842 [TBL] [Abstract][Full Text] [Related]
4. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy. de Visser M; Verwijnen SM; de Jong M Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684 [TBL] [Abstract][Full Text] [Related]
5. Rationale for the use of radiolabelled peptides in diagnosis and therapy. Koopmans KP; Glaudemans AW Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630 [TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical studies of peptide receptor radionuclide therapy. Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630 [TBL] [Abstract][Full Text] [Related]
7. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases. Sosabowsky J; Melendez-Alafort L; Mather S Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415 [TBL] [Abstract][Full Text] [Related]
8. Tumor targeting with Rezazadeh F; Sadeghzadeh N Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570 [TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs. Mariani G; Erba PA; Signore A J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731 [No Abstract] [Full Text] [Related]
12. Radiolabeled regulatory peptides for imaging and therapy. Nanda PK; Lane SR; Retzloff LB; Pandey US; Smith CJ Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):69-76. PubMed ID: 19901831 [TBL] [Abstract][Full Text] [Related]
13. Radiolabeled peptides in the diagnosis and therapy of oncological diseases. Weiner RE; Thakur ML Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051 [TBL] [Abstract][Full Text] [Related]
14. Radiolabeled peptides in oncology: role in diagnosis and treatment. Weiner RE; Thakur ML BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900 [TBL] [Abstract][Full Text] [Related]
15. The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers. Farahani AM; Maleki F; Sadeghzadeh N Anticancer Agents Med Chem; 2020; 20(4):402-416. PubMed ID: 31889492 [TBL] [Abstract][Full Text] [Related]
16. Peptide-based radiopharmaceuticals for targeted tumor therapy. Dong C; Liu Z; Wang F Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337 [TBL] [Abstract][Full Text] [Related]
17. Tumor imaging and therapy using radiolabeled somatostatin analogues. de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476 [TBL] [Abstract][Full Text] [Related]
18. Development of peptide and protein based radiopharmaceuticals. Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103 [TBL] [Abstract][Full Text] [Related]